🔎 Trials Near Me

Akèy › Kansè pankreyas › Oregon › Portland

Etid klinik pou Kansè pankreyas nan Portland, OR

19 etid pou Kansè pankreyas ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Ap rekriteFaz 3
  • Oregon Health and Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07562152

A Study of PHN-012 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1
  • PHN-012-001 Site, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07127874

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Ap rekriteFaz 2/3
  • OHSU Center for Health & Healing 1, Portland
  • Oregon Health and Science University, Portland
  • OSHU Center for Health and Healing 2, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Ap rekriteFaz 3
  • Investigative Site US042, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07522073

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Ap rekriteFaz 3
  • Oregon Health & Science University - OHSU Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07409272

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Ap rekriteEtid obsèvasyon
  • Oregon Health & Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06271291

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Ap rekriteEtid obsèvasyon
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Oregon Health and Science University, Portland
  • ak 1 plis
Laj 50 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT04239573

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Ap rekriteFaz 1 bonè
  • OHSU Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT04005690

Use Of Indocyanine Green In Pancreas Surgery

Ap rekriteEtid obsèvasyon
  • OHSU Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT06084013

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Ap rekriteFaz 3
  • Oregon Health and Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06958328

A Study of MGC026 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Providence Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470

Pancreatic Cancer Early Detection Consortium

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Oregon Health & Science University, Portland
Laj 18 a 90 · Tout sèks · Mizajou Jul 22, 2026 · NCT04970056

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Ap rekrite
  • OHSU Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Jun 16, 2026 · NCT07651358

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Ap rekriteFaz 3
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06998940

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Ap rekriteFaz 1 bonè
  • OHSU Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Mar 23, 2026 · NCT07089940

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Ap rekriteFaz 2
  • Ohio State University-Telemedicine, Portland
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT06906562

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Oregon Health Sciences University, Portland
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Ap rekriteEtid obsèvasyon
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jan 9, 2026 · NCT06073431

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Portland
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè pankreyas nan lòt vil

Lòt etid nan Portland

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.